Cytodyn Inc (CYDY)

[ohm20]

Anyone have any guesses if there are any trials underway for Leronlimab other than COVID-19? If so, would any of those trial patients ever show even mild COVID-19 symptoms if already being treated with Leronlimab?

Leronlimab would not stop you from getting COVID-19 but with the antiviral and anti-inflammatory benefits it would present as mild symptoms.

Second question would be if a COVID-19 trials patient gets treated with Leronlimab and in the course of their COVID-19 treatment doctors discover they have one of the types of Leronlimab potentially treatable cancers, do they....

1) Once patient recovers from COVID-19 send them on to oncology for "traditional" treatment?

2) Once patient recovers from COVID-19 send them directly into the trials for the cancer they are being treated for?

3) Keep patient on Leronlimab and move them directly to EIND for their cancer?

That would depend on what oncologist they see. Most doctors still know little about leronlimab and may want to stick to the tried and true. Once we have clinical trial data for cancer that should start to change.